Michael King
Stock Analyst at EF Hutton
(1.28)
# 2,563
Out of 4,414 analysts
125
Total ratings
34.13%
Success rate
-15.7%
Average return
Main Sectors:
Top Industries:
27 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| APLM Apollomics | Maintains: Buy | $11 → $6.5 | $0.41 | +1,485.37% | 4 | Apr 1, 2024 | |
| SONN Sonnet BioTherapeutics Holdings | Assumes: Buy | $147 | $1.92 | +7,577.08% | 7 | Aug 23, 2023 | |
| LTRN Lantern Pharma | Reiterates: Buy | $11 | $5.49 | +100.36% | 10 | Aug 10, 2023 | |
| BMEA Biomea Fusion | Reiterates: Buy | $32 | $11.93 | +168.23% | 11 | Jun 26, 2023 | |
| JSPR Jasper Therapeutics | Reiterates: Buy | $69 | $23.98 | +185.65% | 10 | Jun 12, 2023 | |
| COEP Coeptis Therapeutics | Assumes: Buy | $10 | $0.37 | +2,605.63% | 7 | May 25, 2023 | |
| HOWL Werewolf Therapeutics | Assumes: Buy | $8.3 | $6.08 | +36.51% | 6 | May 25, 2023 | |
| REGN Regeneron Pharmaceuticals | Reiterates: Buy | $862 | $937.61 | -8.06% | 11 | May 1, 2023 | |
| EXEL Exelixis | Reiterates: Buy | $24 | $22.12 | +8.50% | 10 | Apr 28, 2023 | |
| OCEA Ocean Biomedical | Maintains: Buy | $10 → $17 | $1.40 | +1,114.29% | 3 | Apr 27, 2023 | |
| AGEN Agenus | Reiterates: Buy | $166 | $12.52 | +1,225.88% | 7 | Mar 28, 2023 | |
| XNCR Xencor | Reiterates: Buy | $42 | $23.63 | +77.74% | 5 | Feb 24, 2023 | |
| ALNY Alnylam Pharmaceuticals | Reiterates: Buy | $304 | $150.31 | +102.25% | 2 | Feb 24, 2023 | |
| NTLA Intellia Therapeutics | Maintains: Buy | $123 → $116 | $23.27 | +398.50% | 6 | Feb 24, 2023 | |
| CMPX Compass Therapeutics | Initiates: Buy | $10 | $1.65 | +524.24% | 2 | Dec 16, 2022 | |
| VINC Vincerx Pharma | Maintains: Buy | $25 → $28 | $0.93 | +2,910.75% | 2 | Mar 30, 2022 | |
| SRRK Scholar Rock Holding | Initiates: Buy | $24 | $15.10 | +58.94% | 1 | Mar 23, 2022 | |
| SLRX Salarius Pharmaceuticals | Maintains: Buy | $125 → $100 | $0.53 | +18,853.75% | 2 | Mar 11, 2022 | |
| ANAB AnaptysBio | Maintains: Buy | $43 → $46 | $26.34 | +74.64% | 2 | Mar 8, 2022 | |
| AGIO Agios Pharmaceuticals | Maintains: Buy | $98 → $96 | $34.58 | +177.62% | 6 | Mar 3, 2022 | |
| KTRA Kintara Therapeutics | Maintains: Buy | $300 → $150 | $0.16 | +95,319.85% | 2 | Jan 20, 2022 | |
| XLO Xilio Therapeutics | Initiates: Buy | $36 | $1.05 | +3,328.57% | 1 | Jan 10, 2022 | |
| ELEV Elevation Oncology | Initiates: Buy | $12 | $3.82 | +214.14% | 1 | Dec 23, 2021 | |
| COGT Cogent Biosciences | Maintains: Buy | n/a | $7.29 | - | 2 | Nov 5, 2021 | |
| ARGX argenx SE | Maintains: Market Outperform | n/a | $393.42 | - | 2 | Nov 13, 2017 | |
| DCPH Deciphera Pharmaceuticals | Initiates: Market Outperform | n/a | $25.38 | - | 1 | Oct 23, 2017 | |
| SYRS Syros Pharmaceuticals | Upgrades: Market Outperform | n/a | $5.20 | - | 2 | Sep 28, 2017 |
Apollomics
Apr 1, 2024
Maintains: Buy
Price Target: $11 → $6.5
Current: $0.41
Upside: +1,485.37%
Sonnet BioTherapeutics Holdings
Aug 23, 2023
Assumes: Buy
Price Target: $147
Current: $1.92
Upside: +7,577.08%
Lantern Pharma
Aug 10, 2023
Reiterates: Buy
Price Target: $11
Current: $5.49
Upside: +100.36%
Biomea Fusion
Jun 26, 2023
Reiterates: Buy
Price Target: $32
Current: $11.93
Upside: +168.23%
Jasper Therapeutics
Jun 12, 2023
Reiterates: Buy
Price Target: $69
Current: $23.98
Upside: +185.65%
Coeptis Therapeutics
May 25, 2023
Assumes: Buy
Price Target: $10
Current: $0.37
Upside: +2,605.63%
Werewolf Therapeutics
May 25, 2023
Assumes: Buy
Price Target: $8.3
Current: $6.08
Upside: +36.51%
Regeneron Pharmaceuticals
May 1, 2023
Reiterates: Buy
Price Target: $862
Current: $937.61
Upside: -8.06%
Exelixis
Apr 28, 2023
Reiterates: Buy
Price Target: $24
Current: $22.12
Upside: +8.50%
Ocean Biomedical
Apr 27, 2023
Maintains: Buy
Price Target: $10 → $17
Current: $1.40
Upside: +1,114.29%
Agenus
Mar 28, 2023
Reiterates: Buy
Price Target: $166
Current: $12.52
Upside: +1,225.88%
Xencor
Feb 24, 2023
Reiterates: Buy
Price Target: $42
Current: $23.63
Upside: +77.74%
Alnylam Pharmaceuticals
Feb 24, 2023
Reiterates: Buy
Price Target: $304
Current: $150.31
Upside: +102.25%
Intellia Therapeutics
Feb 24, 2023
Maintains: Buy
Price Target: $123 → $116
Current: $23.27
Upside: +398.50%
Compass Therapeutics
Dec 16, 2022
Initiates: Buy
Price Target: $10
Current: $1.65
Upside: +524.24%
Vincerx Pharma
Mar 30, 2022
Maintains: Buy
Price Target: $25 → $28
Current: $0.93
Upside: +2,910.75%
Scholar Rock Holding
Mar 23, 2022
Initiates: Buy
Price Target: $24
Current: $15.10
Upside: +58.94%
Salarius Pharmaceuticals
Mar 11, 2022
Maintains: Buy
Price Target: $125 → $100
Current: $0.53
Upside: +18,853.75%
AnaptysBio
Mar 8, 2022
Maintains: Buy
Price Target: $43 → $46
Current: $26.34
Upside: +74.64%
Agios Pharmaceuticals
Mar 3, 2022
Maintains: Buy
Price Target: $98 → $96
Current: $34.58
Upside: +177.62%
Kintara Therapeutics
Jan 20, 2022
Maintains: Buy
Price Target: $300 → $150
Current: $0.16
Upside: +95,319.85%
Xilio Therapeutics
Jan 10, 2022
Initiates: Buy
Price Target: $36
Current: $1.05
Upside: +3,328.57%
Elevation Oncology
Dec 23, 2021
Initiates: Buy
Price Target: $12
Current: $3.82
Upside: +214.14%
Cogent Biosciences
Nov 5, 2021
Maintains: Buy
Price Target: n/a
Current: $7.29
Upside: -
argenx SE
Nov 13, 2017
Maintains: Market Outperform
Price Target: n/a
Current: $393.42
Upside: -
Deciphera Pharmaceuticals
Oct 23, 2017
Initiates: Market Outperform
Price Target: n/a
Current: $25.38
Upside: -
Syros Pharmaceuticals
Sep 28, 2017
Upgrades: Market Outperform
Price Target: n/a
Current: $5.20
Upside: -